Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for Lower Limb Perfusion in T2D and PAD (STARDUST)
NCT04881110Phase 4Completed
- Sponsor
- University of Campania Luigi Vanvitelli
- Start
- Feb 2021
- Primary completion
- Dec 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in peripheral artery disease (PAD), type 2 diabetes mellitus (T2DM), sponsored by University of Campania Luigi Vanvitelli. Started Feb 2021; status: completed.
02
Drugs
03
Conditions
peripheral artery disease (PAD)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04881110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04881110.